This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Chemical mediators of inflammation

Authoring team

This vast group are molecules produced for inter- and intracellular signalling.

They are intimately involved in the inflammatory and immune responses as both effectors and a means of co-ordinating the level of activity. Their interaction is undoubtedly complex and poorly understood. It is important to emphasise that in vitro activity does not necessarily equate with a role in vivo.

One means of classifying them is by tissue of origin:

  • plasma-derived: inactive precursors produced in liver and circulate as plasma proteins. Activated by binding specific substance which then trigger proteolysis of the next plasma protein in sequence. Examples include:
    • kinin system
    • clotting system
    • fibrinolytic system
    • complement cascade

  • tissue-derived: a diverse range of substances whose release is triggered by a number of stimuli e.g. direct injury, neurogenic stimuli, immune mechanisms or other inflammatory mediators. Examples include:
    • vasoactive amines: histamine and serotonin
    • eicosanoids - arachidonic acid metabolites
    • acute phase proteins
    • platelet activating factor
    • lysosomal constituents
    • cytokines
    • growth factors

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.